ONC AALL08B1-Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)
This research trial studies a risk-based classification system for patients with newly diagnosed acute lymphoblastic leukemia. Gathering health information about patients with acute lymphoblastic leukemia may help doctors learn more about the disease and plan the best treatment.
Eligibility: Ages: up to 30 years
•Samples from patients registered on the Children Oncology Group (COG)-AALL08B1 protocol and stored in the Hematopathology Laboratory at the University of Washington
◦Pretreatment and after induction therapy samples
PRIOR CONCURRENT THERAPY:
Brenda Wittman, M.D.
COG (Childrens Oncology Group)
- Alaska Research
- Providence Alaska Medical Center